Literature DB >> 2174553

Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.

J Striessnig1, H Glossmann, W A Catterall.   

Abstract

The alpha 1 subunit of the skeletal muscle Ca2+ channel has been specifically photoaffinity labeled with the phenylalkylamine-receptor-selective verapamil derivative (-)-5-(3-azidophenethyl[N-methyl-3H]methylamino)-2-(3,4,5- trimethoxyphenyl)-2-isopropylvaleronitrile ([N-methyl-3H]LU49888). Proteolytic fragments generated by various endoproteases were probed by immunoprecipitation with several sequence-specific antibodies to determine the site of labeling within the primary structure of alpha 1. These results restrict the site of photolabeling by [N-methyl-3H]LU49888 to the region between Glu-1349 and Trp-1391. This segment of alpha 1 contains transmembrane helix S6 of domain IV and the beginning of the long intracellular C-terminal tail. Because of the phenylalkylamine receptor site is only accessible from the intracellular side of the Ca2+ channel, we propose that the intracellular end of helix IVS6 and the adjacent intracellular amino acid residues play an essential role in formation of the phenylalkylamine receptor site. The action of the phenylalkylamines as open-channel blockers suggests that this region may also contribute to formation of the intracellular opening of the transmembrane pore of the Ca2+ channel.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174553      PMCID: PMC55113          DOI: 10.1073/pnas.87.23.9108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Sidedness of reconstituted calcium channels from muscle transverse tubules as determined by D600 and D890 blockade.

Authors:  H Affolter; R Coronado
Journal:  Biophys J       Date:  1986-03       Impact factor: 4.033

2.  Channel hands.

Authors:  J Babitch
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

3.  Primary structure of the receptor for calcium channel blockers from skeletal muscle.

Authors:  T Tanabe; H Takeshima; A Mikami; V Flockerzi; H Takahashi; K Kangawa; M Kojima; H Matsuo; T Hirose; S Numa
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

4.  Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.

Authors:  M L Garcia; V F King; P K Siegl; J P Reuben; G J Kaczorowski
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

5.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

6.  Identification of an intracellular domain of the sodium channel having multiple cAMP-dependent phosphorylation sites.

Authors:  S Rossie; D Gordon; W A Catterall
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

7.  Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.

Authors:  A Goll; H Glossmann; R Mannhold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

8.  Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane?

Authors:  J Hescheler; D Pelzer; G Trube; W Trautwein
Journal:  Pflugers Arch       Date:  1982-06       Impact factor: 3.657

9.  (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.

Authors:  A Goll; D R Ferry; J Striessnig; M Schober; H Glossmann
Journal:  FEBS Lett       Date:  1984-10-29       Impact factor: 4.124

10.  Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.

Authors:  J Striessnig; H G Knaus; M Grabner; K Moosburger; W Seitz; H Lietz; H Glossmann
Journal:  FEBS Lett       Date:  1987-02-23       Impact factor: 4.124

View more
  32 in total

1.  The presynaptic calcium channel is part of a transmembrane complex linking a synaptic laminin (alpha4beta2gamma1) with non-erythroid spectrin.

Authors:  W J Sunderland; Y J Son; J H Miner; J R Sanes; S S Carlson
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Control of ion conduction in L-type Ca2+ channels by the concerted action of S5-6 regions.

Authors:  Susan M Cibulsky; William A Sather
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

3.  Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation.

Authors:  R J Röbe; S Grissmer
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  A molecular blueprint for the pore-forming structure of voltage-gated calcium channels.

Authors:  A Grove; J M Tomich; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

5.  Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure.

Authors:  P Milberg; M Fink; C Pott; G Frommeyer; J Biertz; N Osada; J Stypmann; G Mönnig; M Koopmann; G Breithardt; L Eckardt
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel.

Authors:  H Rauer; S Grissmer
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 7.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

Review 8.  Molecular properties of sodium and calcium channels.

Authors:  W A Catterall
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

9.  Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

Authors:  S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

10.  Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.

Authors:  Alison Oliveto; Michael Mancino; Nichole Sanders; Christopher Cargile; J Benjamin Guise; Warren Bickel; W Brooks Gentry
Journal:  Eur J Pharmacol       Date:  2013-03-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.